v3.26.3
Stock-Based Compensation Plans - Narrative (Details)
$ in Millions
3 Months Ended 12 Months Ended
Nov. 05, 2025
shares
Aug. 31, 2026
USD ($)
shares
May 31, 2026
shares
Oct. 09, 2021
plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares of common stock authorized (in shares) 15,000,000      
Number of equity incentive plans | plan       2
Restricted Stock Units (RSUs) And Restricted Stock Awards (RSAs) | Common Stock Plan 2022        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants to date (in shares)   23,200,000    
Restricted Stock Units (RSUs) And Restricted Stock Awards (RSAs) | Common Stock Plan 2024        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants to date (in shares)   20,400,000    
Common stock, capital shares reserved for future issuance (in shares)   7,600,000    
Restricted Stock Units (RSUs) And Restricted Stock Awards (RSAs) | Employment Inducement Award        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Grants to date (in shares)   600,000    
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized stock compensation expense | $   $ 0.1    
Unrecognized stock compensation expense, period for recognition (in years)   7 months 6 days    
Granted (in shares)   0    
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized stock compensation expense | $   $ 150.6    
Unrecognized stock compensation expense, period for recognition (in years)   2 years 7 months 6 days    
Granted (in shares)   696,797    
Performance Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized stock compensation expense | $   $ 90.8    
Unrecognized stock compensation expense, period for recognition (in years)   3 years 6 months    
Granted (in shares)   0 4,500,000